1.
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes
by Watson, A. M. D
Diabetologia, 2013, Vol.56 (5), p.1155-1165
2.
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
by Watson, A. M. D
Diabetologia, 2009, Vol.53 (1), p.192-203
3.
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
by Watson, A. M. D
Diabetologia, 2010, Vol.54 (3), p.681-689
4.
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes
by Koïtka, A
Diabetologia, 2009, Vol.53 (3), p.584-592
5.
Tumour cyclic AMP binding proteins : an independent prognostic factor for disease recurrence and survival in breast cancer
by MILLER, W. R
Breast cancer research and treatment, 1993, Vol.26 (1), p.89-94
6.
Serum 25-Hydroxyvitamin D Concentration and Mortality from Heart Failure and Cardiovascular Disease, and Premature Mortality from All-Cause in United States Adults
by Liu, Longjian, MD, PhD, MSc
The American journal of cardiology, 2012, Vol.110 (6), p.834-839
7.
The H-ras oncogene product p21 and prognosis in human breast cancer
by WATSON, D. M. A
Breast cancer research and treatment, 1991, Vol.17 (3), p.161-169
8.
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease
by Kiesslich, R
Gut, 2012, Vol.61 (8), p.1146-1153
9.
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
by Dixon, W G
Annals of the rheumatic diseases, 2010, Vol.69 (3), p.522-528
10.
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
by Galloway, J B
Annals of the Rheumatic Diseases, 2011, Vol.70 (10), p.1810-1814
11.
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics R...
by Dixon, W G
Annals of the rheumatic diseases, 2010, Vol.69 (6), p.1086-1091
12.
CBT4BN: A Randomized Controlled Trial of Online Chat and Face-to-Face Group Therapy for Bulimia Nervosa
by Zerwas, Stephanie C
Psychotherapy and psychosomatics, 2016, Vol.86 (1), p.47-53
13.
Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
by Verstappen, Suzanne M M
Annals of the Rheumatic Diseases, 2011, Vol.70 (5), p.823-826
14.
The cutting edge - Micro-CT for quantitative toolmark analysis of sharp force trauma to bone
by Norman, D G
Forensic science international, 2017, Vol.283, p.156
15.
Comparison of stapled haemorrhoidopexy with traditional excisional surgery for haemorrhoidal disease (eTHoS): a pragmatic, multicentre, randomised controlled trial
by Watson, Angus J M, Prof
The Lancet (British edition), 2016, Vol.388 (10058), p.2375-2385
16.
Temperament and Sensory Features of Children with Autism
by Brock, M. E
Journal of autism and developmental disorders, 2012, Vol.42 (11), p.2271-2284
17.
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Re...
by Soliman, Moetaza M
Annals of the rheumatic diseases, 2011, Vol.70 (4), p.583-589
18.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
by Rudin, Charles M, Prof
The lancet oncology, 2016, Vol.18 (1), p.42-51
19.
A Global Mitigation Hierarchy for Nature Conservation
by Arlidge, William N S
Bioscience, 2018, Vol.68 (5), p.336-347
20.
Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis
by Cole, Christian, PhD
Journal of allergy and clinical immunology, 2014, Vol.134 (1), p.82-91
